CLDI Stock Analysis: Buy, Sell, or Hold?
CLDI - Calidi Biotherapeutics, Inc.
$0.21
-0.01 (-2.77%)
▼
5d:
-2.73%
30d:
-18.28%
90d:
-75.58%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 13, 2026
3d
Get Alerted When CLDI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CLDI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: CLDI shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: CLDI is currently trading at $0.21, which is considered oversold relative to its 30-day fair value range of $0.22 to $0.26.
Technical Outlook: Technically, CLDI is in a strong downtrend. Immediate support is located at $0.19, while resistance sits at $0.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $120.00 (+56909.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CLDI is in a strong downtrend. Immediate support is located at $0.19, while resistance sits at $0.27.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $120.00 (+56909.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.22 -
$0.26
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Trading 56909.4% below Wall St target ($120.00)
Trading Range Analysis
30-Day Trading Range
$0.22 -
$0.26
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.19
Resistance Level
$0.27
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.04
Wall Street Target
$120.00
(+56909.4%)
Share & Embed Analysis
Last updated: May 09, 2026 3:51 PM ET
Data refreshes hourly during market hours. Next update: 4:51 PM
Data refreshes hourly during market hours. Next update: 4:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLDI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Allan Camaisa
SELL
850 shares
2025-12-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 58 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$230 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 62 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
